Contact your trial team or GP promptly if you experience: Persistent or severe nausea, vomiting, or diarrhoea that prevents adequate fluid or food intake Signs of dehydration, such as dizziness, dark urine, or reduced urination Severe or persistent abdominal pain, which may rarely indicate pancreatitis a known risk with GLP-1 receptor agonist therapies or gallbladder problems [18] [21] Rapid or irregular heartbeat (palpitations) Significant injection site reactions, including signs of infection (redness, warmth, swelling, or discharge) Symptoms of low blood sugar (hypoglycaemia) if you are also taking insulin or a sulfonylurea, such as shakiness, sweating, or confusion If you are unsure whether your symptoms require urgent attention, contact NHS 111 (by phone or online at 111.nhs.uk) for advice
This release happens within the first 15 to 30 minutes after a meal begins
To ensure a safe transition when switching programs, you must consult with our medical provider
Be precise: Know the date and time of your last dose/injection
Related Posts: Recent Posts Why Oral Health Should Be Part of Your Self-Care Routine All About Floss: Whats the Best Dental Flossing Tool and Method
You can explore specific meal planning strategies in our calorie guide for semaglutide or our tirzepatide calorie guide
.jpg)
